172 related articles for article (PubMed ID: 29630507)
1. Observational studies on macroprolactin in a routine clinical laboratory.
Barth JH; Lippiatt CM; Gibbons SG; Desborough RA
Clin Chem Lab Med; 2018 Jul; 56(8):1259-1262. PubMed ID: 29630507
[TBL] [Abstract][Full Text] [Related]
2. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
Suliman AM; Smith TP; Gibney J; McKenna TJ
Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
[TBL] [Abstract][Full Text] [Related]
3. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
4. Free prolactin determinations in hyperprolactinemic men with suspicion of macroprolactinemia.
Sapin R; Gasser F; Grucker D
Clin Chim Acta; 2002 Feb; 316(1-2):33-41. PubMed ID: 11750272
[TBL] [Abstract][Full Text] [Related]
5. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
[TBL] [Abstract][Full Text] [Related]
6. The impact on clinical practice of routine screening for macroprolactin.
Gibney J; Smith TP; McKenna TJ
J Clin Endocrinol Metab; 2005 Jul; 90(7):3927-32. PubMed ID: 15811931
[TBL] [Abstract][Full Text] [Related]
7. Macroprolactinemia: the consequences of a laboratory pitfall.
Toldy E; Löcsei Z; Szabolcs I; Góth MI; Kneffel P; Szöke D; Kovács GL
Endocrine; 2003 Dec; 22(3):267-73. PubMed ID: 14709800
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of macroprolactin detected by Elecsys 2010.
Sánchez-Eixerés MR; Mauri M; Alfayate R; Graells ML; Miralles C; López A; Picó A
Horm Res; 2001; 56(3-4):87-92. PubMed ID: 11847468
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of macroprolactin in the form of prolactin-immunoglobulin G complexes by immunoprecipitation with anti-human IgG-agarose.
Schiettecatte J; De Schepper J; Velkeniers B; Smitz J; Van Steirteghem A
Clin Chem Lab Med; 2001 Dec; 39(12):1244-8. PubMed ID: 11798085
[TBL] [Abstract][Full Text] [Related]
10. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
11. Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?
Livingston M; Hashmi SF; Ramachandran S; Laing I; Heald A
Clin Endocrinol (Oxf); 2024 May; 100(5):450-458. PubMed ID: 38534014
[TBL] [Abstract][Full Text] [Related]
12. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.
McCudden CR; Sharpless JL; Grenache DG
Clin Chim Acta; 2010 Feb; 411(3-4):155-60. PubMed ID: 19895797
[TBL] [Abstract][Full Text] [Related]
13. Quantitative adjustment for macroprolactin is an integral part of laboratory assessment of hyperprolactinaemia.
Heald AH; Blantern E; Anderson SG; Radford D; Qureshi Z; Nair S; Waldron J; Davies M; McCulloch A; Kane J
Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):376-80. PubMed ID: 22576261
[TBL] [Abstract][Full Text] [Related]
14. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.
Whitehead SJ; Cornes MP; Ford C; Gama R
Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991
[TBL] [Abstract][Full Text] [Related]
15. Macroprolactinemia Detection by Magnetically Assisted Polyethylene Glycol Precipitation: Potential for Automation.
Smith T; Stern E; Tan E; Vacic A; Fahie-Wilson M
J Appl Lab Med; 2020 May; 5(3):494-505. PubMed ID: 32445359
[TBL] [Abstract][Full Text] [Related]
16. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms.
Beltran L; Fahie-Wilson MN; McKenna TJ; Kavanagh L; Smith TP
Clin Chem; 2008 Oct; 54(10):1673-81. PubMed ID: 18719199
[TBL] [Abstract][Full Text] [Related]
17. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
Overgaard M; Pedersen SM
Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
[TBL] [Abstract][Full Text] [Related]
18. [Macroprolactin detection: a new approach].
Sapin R; Gasser F; Fischbach E; Grucker D
Ann Biol Clin (Paris); 2000; 58(6):729-34. PubMed ID: 11098170
[TBL] [Abstract][Full Text] [Related]
19. Frequency of Macroprolactin in Hyperprolactinemia.
Sherazi NA; Baig MZ; Khan AH
J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
[TBL] [Abstract][Full Text] [Related]
20. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
